DiaGen Ai Inc. Announces its Selection as a Top 100 Canadian Tech Company VANCOUVER, BC, CANADA, April 11, 2025 /EINPresswire / -- DiaGen Ai I ...

From molecule and peptide discovery to optimization and drug ... general applicability of AI technology towards the healthcare sector, particularly drug discovery, diagnostics, and vaccines ...

As many of you have heard me say in the past, computational and AI-driven approaches ... across for antibody drug conjugate development or peptide or drug, drug conjugate development.

The paper, authored by researchers across several Indian institutions, details how AI ... optimization, enabling researchers to design more efficient and patient-friendly dosage forms.

Longhorn Vaccines and Diagnostics, a One Health company developing treatments and diagnostic tools for global public health and zoonosis concerns, will present new data from universal influenza ...

In a study published in Science, a research team led by Prof. Ye Jian from the Institute of Microbiology of the Chinese ...

In a major step toward more reliable AI-assisted molecular design, researchers from National Taiwan University have ...

What to do: Consult a health care professional if you have used an unauthorized injectable peptide drug and have health concerns. Do not buy or use unauthorized drugs. Only buy prescription drugs from ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Health Canada is warning about unauthorized injectable peptide drugs seized from the Optimum Wellness Centre on Southport Road in Calgary, Alberta (#108, 10333 Southport Rd SW). Peptide drugs ...

The injectable GLP-1 drugs are peptides — small fragments of proteins. (GLP stands for glucagon-like peptide.) Peptides are digested by the stomach. So, in order to make an oral GLP-1 ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.